Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

Merriam PA, Sikov WM

Breast Cancer: Targets and Therapy 2011, 3:139-150

Published Date: 26 October 2011